Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/01/2021 11 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Rapamycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 6 0
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 11 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Daunorubicin Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/12/2021 2 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/08/2021 25 7
Bafilomycin A1 Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021 2 0